Sermorelin vs tesamorelin: who had growth or fat changes?
Sermorelin increased children's growth and older men's blood hormone levels. Tesamorelin produced the adult fat findings in different people. Your benefit from one drug can't be assumed from results with the other.
What is the short answer to Sermorelin vs tesamorelin?
Tesamorelin trials found that adults lost fat packed around organs in the belly. Children with growth problems grew faster during Sermorelin trials. Older men receiving Sermorelin also had higher blood hormone levels. Sermorelin vs tesamorelin starts with which drug the people received, then whether the tested benefit is one that matters for your health.
Both medicines prompt the gland that makes growth hormone. Blood breaks Sermorelin apart rapidly after the medicine arrives. Changes to tesamorelin help protect the drug against that rapid breakdown. Similar actions don't establish identical results for the people receiving the medicines, so the children's added height and adults' fat changes remain separate findings that cannot promise a matching benefit for you.
Why do Sermorelin and tesamorelin start a similar hormone response?
Both drugs copy the action of the same natural brain hormone [13]. The gland responds by releasing growth hormone into blood. Hormones from brain and liver slow release between the separate bursts [4]. This shared action doesn't mean the medicines remain active equally long in blood.
The hormone in a direct shot comes from outside the body. These two medicines instead leave your gland producing growth hormone. Blood enzymes are proteins that cut medicines apart; these enzymes broke the drugs into smaller parts. The ease of cutting helps determine how long each medicine keeps working.
Sermorelin copies the shortest part that can start hormone release [3]. That part lacks protection against quick breakdown once in blood. Scientists changed tesamorelin to make the medicine harder to cut apart. The longer action allowed daily treatment for its approved health condition.
Sermorelin vs tesamorelin: why does their time in blood differ?
Half the Sermorelin left blood within about 10-12 minutes after a vein shot. Growth hormone stayed higher for roughly 3 hours [3]. The gland continued releasing hormone while the medicine's blood level fell. For sermorelin vs tesamorelin, how long medicine remains and how long the gland responds are separate questions.
Blood enzymes cannot break tesamorelin apart as quickly as Sermorelin. That protection allowed daily treatment in trials lasting weeks or months [6][9]. Each drug starts a similar response from the gland's hormone-making cells. Their differences in breakdown affect how long medicine can continue prompting the gland.
The page about blood clearing Sermorelin explains the two blood tests. Scientists also change other medicines to protect weak points against breakdown. Some drugs attach to one of the proteins carrying substances around in blood. That attachment delays removal, but doesn't itself prove a better treatment for you.
Which fat-loss findings belong to tesamorelin rather than Sermorelin?
Adults living with HIV received tesamorelin in the belly-fat trial. The immune system protects against illness; HIV damages that defense. Adults lost more fat around belly organs than the placebo group [9]. A separate trial examined where men with HIV carried fat [10].
A separate 152-adult tesamorelin trial followed treatment over 20 weeks. The liver hormone rose 117%, more than doubling its starting amount. Even after that increase, the hormone remained within healthy limits. Fat accounted for a smaller percentage of the adults' total weight [6].
Sermorelin increased children's yearly height gain from about 4.1 to 7-8 centimeters [1]. Short children with normal hormone levels also grew faster [8]. Older men reached younger men's levels for the liver hormone along with growth hormone [2]. None of those Sermorelin results directly measured adult fat loss.
A separate experiment treated 47 men with the natural brain hormone and an experimental stomach-hormone copy [7]. The men's growth hormone rose by different amounts. Belly fat and two blood checks explained 60% of how much those responses differed. That percentage concerns differences in hormone released, rather than the proportion of men helped.
Men carrying more fat around belly organs generally released less hormone. The researchers couldn't explain all the differences between men's responses. Neither the percentage nor the belly-fat link measures pounds lost. Your Sermorelin fat-loss question still needs a study that tests Sermorelin directly.
Were Sermorelin and tesamorelin tested for the same health problems?
Sermorelin trials treated children with growth problems rather than adults losing fat. Children lacking growth hormone grew taller more quickly [1]. Short children with normal hormone levels also added height faster [8]. For the two tested hormones, older men reached levels like those of younger men [2].
Tesamorelin trials measured fat changes in adults with HIV. The adults lost more fat around belly organs than people receiving placebo [9]. Another trial checked fat placement in men with HIV [10]. Those adults had different concerns from growing children and older men with lower hormones, so a result involving HIV and belly fat cannot answer every question about treatment for your health.
A separate trial was a 152-adult tesamorelin study over 20 weeks. The liver hormone rose 117% and fat formed less of body weight [6]. That increase meant more than twice the amount present before treatment. The final amount remained within healthy limits, so a large increase alone doesn't mean an unhealthy blood level.
What treatment did approval cover for Sermorelin and tesamorelin?
2008: The company withdrew its approved US Sermorelin product for commercial reasons [5]. The decision was commercial; no finding of harmful or ineffective treatment caused the withdrawal. FDA's temporary group 1 rules allow pharmacy mixing while ingredients remain under review. The rules don't approve each mixture or establish a benefit for aging adults.
Tesamorelin's approval covers unusual fat changes associated with HIV. The approval doesn't cover general weight loss or treatment of aging. Sermorelin likewise has no approval for those general adult uses. A result from a different drug or health problem cannot widen the approval for your treatment.
Drug-tested sports prohibit growth hormone drugs such as these medicines. The gland keeping its natural checks doesn't change that sports rule. Amounts given in a trial also don't determine your personal treatment. Your own health needs more than a result measured in other people.